Clinical Trial Update: Diagnostic and Prognostic Utility of Pentraxin 3 in Patients With Acute STEMI Undergoing Primary PCI [NA]

View source ↗

Summary

Clinical trial update examining the diagnostic and prognostic value of pentraxin 3 in patients with ST-elevation myocardial infarction undergoing primary PCI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Snippet

Sponsor: Assiut University | Conditions: Myocardial Infarction | NA | Status: UNKNOWN